Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term safety of MK-0653H in Japanese patients with hypercholesterolemia
NCT02748057Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- May 2016
- Primary completion
- Dec 2017
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of ezetimibe, rosuvastatin in hypercholesterolemia, familial hypercholesterolemia (FH), sponsored by Organon & Co.. Started May 2016; status: completed.
02
Drugs
ezetimiberosuvastatin
03
Conditions
hypercholesterolemiafamilial hypercholesterolemia (FH)
Beyond the preview
Go deeper on NCT02748057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02748057.